A hospital north of Chicago has temporarily stopped coronavirus vaccination for its staff after experiencing hostile reactions from four employees, a report said.
A Chicago-based Fox 32 report said three employees were recovering at home while a fourth was receiving medical attention.
Libertyville, Ill. The Pfizer vaccine injection was temporarily halted as a precautionary measure at Advocate Kendall Medical Center – about 39 miles north of Chicago – in a statement, officials said. But other sites in the organization, including eight more in Illinois and three in Wisconsin, continued vaccination without interruption, officials told Fox32.
The medical center noted that the four affected workers represent only a fraction of the 3,000 employees of the organization who have been vaccinated since the Pfizer and bayonet tech vaccines became available earlier this week.
Trump signs 2-day stopgap coronavirus to send more time to Congress bill to register confidence
Officials said a stop at Libertyville would give them a better understanding of why the reaction might occur, Fox32 reported.
Alaskan reactions
On Wednesday, state officials in Alaska reported that two health care workers in that state had experienced allergic reactions to the Pfizer product.
A worker, described as a middle-aged woman with no previous allergy history, stabilized after treatment on Tuesday following rapid heartbeat, shortness of breath and skin rashes and redness, CBS News reported. He was admitted to Junau Hospital for monitoring.
Another employee experienced mild symptoms, including eye puffiness, lightheadedness, and sore throat, the report said.
CBS News reports that the Alaskan hospital has vaccinated about a quarter of the 400 employees who made the requests.
Click here for full coronavirus coverage
The Pfizer and Bioentech vaccines were approved by the Food and Drug Administration earlier this month, with shipments set to begin on December 13 and vaccinations continue a day later.
On Friday, the FDA approved a second vaccine made by Moderna.
Federal officials have announced contracts for a total of 200 million doses of Moderna products and 100 million doses of Pfizer products.
Kailash Rivas of Fox News contributed to this story.
